Paul Berns

Mr. Berns is a board member for Unity Biotechnology, EQRX, and Chairman of Epirum Bio. He previously served as President and Chief Executive Officer at Anacor Pharmaceuticals, Inc., a biopharmaceutical company, from 2014 until its acquisition by Pfizer, Inc. in 2016. Mr. Berns served as President and Chief Executive Officer of Allos Therapeutics, Inc., a biotechnology company, from 2006 to 2012 and was President and Chief Executive Officer of Bone Care International, Inc., a specialty pharmaceutical company, from 2002 to 2005

Prior to that, Mr. Berns was Vice President and General Manager of the immunology, oncology and pain therapeutics business unit of Abbott Laboratories. He also served as Vice President, Marketing of BASF Pharmaceuticals/Knoll. Earlier in his career, Mr. Berns held various positions, including senior management roles, at Bristol-Myers Squibb Company.

Mr. Berns received his B.S. in Economics from the University of Wisconsin.